Improved Physical Performance after Treatment of Renal Anemia with Recombinant Human Erythropoietin

Authors:
  • BNBarbara Nonnast-Daniel
    Barbara Nonnast-Daniel
  • ABAndreas Böcker
    Andreas Böcker
  • UFUlrich Frei
    Ulrich Frei

Abstract
The physical performance of 12 anemic patients on renal dialysis was investigated following treatment of renal anemia with recombinant human erythropoietin (rhEPO; 40–120 U/kg, 3 times a week). Exercise intensity at a heart rate of 130 beats/min (PWC130) on a bicycle ergometer was assessed before rhEPO treatment, after reaching the target hematocrit (73 ± 18 days), and in the maintenance phase (211 ± 53 days). Hemoglobin concentrations measured at these time points were 7.3 ± 1.2,11.9 ± 1.5, and 12.1 ± 1.4 g/dl, respectively. PWC130 rose from 77 ± 27 to 104 ± 37 and 104 ± 51 W, respectively. Aerobic threshold (i.e. blood lactic acid concentration of 2 mmol/l) shifted to higher workloads indicating improved muscle oxygen supply.